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Although overall incidence is rare, leukemia is
the most common type of childhood cancer,
accounting for 30% of all cancers diagnosed
in children younger than 15 years (Linet
1999). Within this population, acute lym-
phocytic leukemia (ALL) occurs approxi-
mately ﬁve times more frequently than acute
myelogenous leukemia (AML) and accounts
for approximately three-quarters of all child-
hood leukemia diagnoses (Gurney et al.
1995; Pui 1997, 2000; Zipf et al. 2000).
Chronic myeloid leukemias make up most
of the other childhood leukemia cases.
Childhood cases account for about 12% of all
leukemias but make up > 60% of ALL cases
(Sandler and Ross 1997).
In the United States, the incidence of
childhood ALL increased between 1975 and
2002; however, this increase was not statisti-
cally significant. The observed increase may
be due in part to changes in diagnostic prac-
tice and accuracy and improved reporting.
The incidence rate of childhood ALL is now
stable at three to four new cases per year per
100,000 children who are younger than
15 years, with a peak incidence at approxi-
mately 2–5 years of age (Greenlee et al. 2000;
Gurney et al. 1995; Margolin et al. 2001;
Ross et al. 1994; Swensen et al. 1997). For
childhood AML, the peak incidence rate
occurs during the first year of life then
decreases steadily through 4 years of age,
where it remains relatively constant through-
out childhood (Gurney et al. 1995). 
The incidence of ALL, particularly T-cell
ALL, is slightly higher among boys than girls.
(Kersey et al. 1973; Margolin et al. 2001; Ries
et al. 1998; Zahm and Devesa 1995). Girls,
however, have a higher incidence of all
leukemias during the ﬁrst year of life (Gurney
et al. 1995; Ries et al. 1998). No differences in
incidence of AML exist between girls and boys.
Throughout childhood, the incidence rate
of ALL among African American children is
approximately half the rate among Caucasian
children. During the ﬁrst few years of life, the
incidence rate of AML among African
American children is approximately one-third
the rate among Caucasian children; however,
African American children ≥ 3 years of age
have higher rates than Caucasians (Gurney
et al. 1995; Pollock et al. 2000; Zahm and
Devesa 1995).
Until the early 1980s, leukemia was the
most common cause of death due to cancer
among children in the United States (Zipf
et al. 2000). The mortality rate for all child-
hood leukemias decreased by 20% from 1975
through 1995 (Linet et al. 1999), and the rate
of children dying of leukemia has signifi-
cantly decreased compared with the death
rate from childhood brain tumors (Bleyer
et al. 1998; Ries et al. 1998).
The overall cure rate for childhood ALL is
now approximately 75–80%; however, for
AML the cure rate is between 40 and 45%
(Pui et al. 2003). In earlier large national tri-
als, treatment results for African American
children had not been as impressive as they
were for Caucasian children (Kalwinsky et al.
1985; Pinkel 1993). A recent study performed
at St. Jude Children’s Hospital compared the
clinical outcomes of therapy for African
American and Caucasian children with ALL
and concluded that with equal access to effec-
tive antileukemic therapy, children of both
racial groups can expect the same high rate of
ALL cure (Pui et al. 2003). However, another
author concluded that ethnic or cultural dif-
ferences in adherence to treatment have not
been examined systematically in sufficiently
large populations in the United States to draw
meaningful conclusions regarding the impact
of nonadherence on ethnic and racial differ-
ences in outcome of children with ALL
(Bhatia 2004). 
Risk Factors
Epidemiologic studies of acute leukemias in
children have examined a number of possible
risk factors (e.g., environmental, genetic, or
infectious) in an effort to determine the etiol-
ogy of the disease. Only one environmental
risk factor (ionizing radiation) has been sig-
nificantly linked with either ALL or AML;
most environmental risk factors [e.g., electro-
magnetic fields (EMFs), cigarette smoking]
have been weakly or inconsistently associated
with either form of childhood leukemia. 
Because childhood leukemia is a rare
occurrence, prospective studies are difﬁcult to
conduct, and therefore studies most fre-
quently use a retrospective case–control
design. Although easier to conduct, these
studies have several inherent limitations
(Schulz and Grimes 2002). For example, bias
may be introduced into a retrospective study
because exposure is measured indirectly, is
self-reported, and may be differentially
recalled by parents of a well, versus a sick,
child (Infante-Rivard and Jacques 2000). Bias
may also be introduced if a certain segment of
the population does not respond to the study
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30 November 2006]survey. Other limitations include a relatively
small number of case children, the number of
spurious results that arise from making many
comparisons, and the questionable relevance
of cross-sectional sampling after illness has
developed, given the latency of the disease
(Schulz and Grimes 2002). Despite these
limitations, results from epidemiologic
research that identiﬁes environmental risk fac-
tors for childhood leukemia can support
measures to alleviate potentially harmful
exposures and reduce the risk for disease. 
The environmental risk factors we discuss
in this article include some of the more
researched and controversial topics including
ionizing and nonionizing radiation, chemicals
such as hydrocarbons and pesticides, alcohol,
tobacco use, and illicit drug use. Knowledge of
these particular risk factors can be used to sup-
port measures to alleviate potentially harmful
exposures and reduce the risk of disease. We
also review genetic and infectious risk factors
and other variables, including maternal repro-
ductive history and birth characteristics. 
Environmental Factors
Ionizing radiation. Ionizing radiation is one
of the few exposures for which the causal rela-
tionship with childhood leukemia, particularly
AML, has been established (Mahoney et al.
2004; Ron 1998; Sali et al. 1996; United
Nations Scientiﬁc Committee on the Effects
of Atomic Radiation 1994). The magnitude
of the risk depends on the dose of radiation,
the duration of exposure, and the age of the
individual at the time of exposure. Studies
have demonstrated the relationship between
the degree of irradiation and occurrence of
leukemia (Miller 1967; Moloney 1955). For
example, leukemia rates among survivors who
were within 1,000 m of the atomic bomb
explosions at Hiroshima and Nagasaki, Japan,
were 20-fold higher than rates among the gen-
eral population (Mahoney 1955). The poten-
tial effect of ionizing radiation exposure on
children may occur during preconception,
pregnancy, or the postnatal period. 
Paternal preconception exposure and close
proximity to a nuclear facility. Numerous
epidemiologic studies have investigated the
potential association between childhood
leukemia and paternal ionizing radiation expo-
sure in the workplace before conception or
preconception, also referred to as “preconcep-
tion paternal irradiation” (PPI). Some studies
have found an association (Gardner 1991;
Gardner et al. 1990; McKinney et al. 1991;
Meinert et al. 1999; Roman et al. 1993; Shu
et al. 1994), whereas others have not (Doll
et al. 1994; Kinlen et al. 1993; Little 1990;
McLaughlin et al. 1993; Shu et al. 2002;
Urquhart et al. 1991; Watson 1991). 
Gardner et al. (1990) examined whether
the observed excess of childhood leukemia was
related to nearness to Sellaﬁeld nuclear plant
in the West Cumbria district of the United
Kingdom from 1950 to 1985. Relative risk
was higher for leukemia in children born near
Sellaﬁeld and for children of fathers employed
at the plant at their conception [relative risk
(RR) = 2.4; 95% confidence interval (CI),
1.04–5.7] and higher for children of fathers
receiving a total preconceptual ionizing radia-
tion dose of 100 mSv or more (RR = 6.4;
95% CI, 1.57–26.3). Gardner et al. (1990)
hypothesized that irradiation of the testes may
be leukomogenic in the offspring. The conclu-
sions of this study have received significant
criticism (Doll et al. 1994; Neel and Schull
1991). First, no excess leukemia was noted in
the rest of Cumbria where > 90% of the births
to Sellaﬁeld employees occurred (Draper et al.
1993). Second, data on the children of male
atomic bomb survivors have not shown an
increased incidence of leukemia (Yoshimoto
et al. 1990), despite receiving a significantly
greater dose of radiation than the children’s
fathers at Sellafield. The results reported by
Gardner et al. (1990) would suggest a much
greater genetic sensitivity to radiation and
therefore would be less plausible (Doll et al.
1994; Little 1990). Third, the results from the
Gardner et al. (1990) study have not been
substantiated by other studies that detected no
statistically significant excess of leukemia in
relation to nuclear facilities in the following
locations: 
• Scotland from 1958 to 1990 (Kinlen et al.
1993), including near the Dounreay nuclear
installation in Caithness (Urquhart et al.
1991) 
• Ontario, Canada, near ﬁve nuclear installa-
tions (McLaughlin et al. 1993) 
• Southern England, near two sites (Roman
et al. 1993), and in three areas of northern
England (McKinney et al. 1991) 
McKinney et al. (1991) did show a nonstatis-
tically signiﬁcant increase between childhood
leukemia and reported preconceptual expo-
sure of fathers to ionizing radiation [odds
ratio (OR) = 2.35; 95% CI, 0.92–6.2]. This
study overlapped with another study and the
quantity of the exposure to ionizing radiation
was not determined (McKinney et al. 1991). 
With regard to diagnostic X rays, Shu
et al. 1994) showed an increased risk for
childhood leukemia related to paternal diag-
nostic x-ray exposure before conception in
two separate studies. In the 1994 study, an
increased risk was noted if two or more X rays
of the lower abdomen were performed (OR =
3.8; 95% CI, 1.5–9.6). No increased risk was
noted in the Shu et al. (2002) study, however,
if the data were restricted to lower abdominal
X rays, the more relevant area of exposure. 
Mechanisms of potentiation by PPI are
discussed in detail elsewhere (Lord 1999).
Maternal preconception occupational exposure
has not been shown to significantly increase
the risk for childhood leukemia (Meinert et al.
1999; Shu et al. 1994).
In utero exposure to ionizing radiation.
Many studies have attempted to ascertain the
effect of in utero radiation exposure and the
development of leukemia—particularly related
to the atomic bomb exposures in Japan at the
end of World War II, the 1986 Chernobyl
(Russia) accident, or exposure to diagnostic
X rays. An increased risk of childhood
leukemia in the offspring of atomic bomb sur-
vivors has yet to be shown (Doll and Wakeford
1997; Neel 1991; Yoshimoto et al. 1988).
Some studies on the Chernobyl accident,
which led to widespread radioactive fallout in
Europe, have found an increased risk for
leukemia in children exposed in utero while liv-
ing in areas exposed to ionizing radiation after
the accident (Noshchenko et al. 2001; Petridou
et al. 1996). The observed effects are in ques-
tion, however, and other studies have not con-
ﬁrmed an increase in risk (Michaelis et al. 1997;
Sali et al. 1996; Steiner et al. 1998). 
In a critical review of several European
studies undertaken 10 years after Chernobyl,
overall, no signiﬁcant association between the
risk of childhood leukemia in children
0–14 years of age and exposure from the
Chernobyl accident was found (Sali et al.
1996). However, a small risk could not be
ruled out secondary to limited power and the
fact that most studies were descriptive. In a
Swedish study, the risk for ALL in children
< 5 years of age in highly contaminated areas
was increased although not statistically signiﬁ-
cant (OR = 1.5; 95% CI, 0.8–2.6) (Hjalmars
et al. 1994). Last, in a review of 36 cancer
registries in Europe for children 0–14 years of
age, the risk for leukemia was increased
slightly in the postaccident period, but the
overall geographical patterns of change
uncovered no relation to the estimated expo-
sure to radiation (Parkin et al. 1993, 1996).
Many studies have assessed the risk of
in utero exposure to diagnostic X rays and the
development of childhood leukemia, with con-
ﬂicting results. The potential risk of leukemia
in children exposed to diagnostic X rays was
ﬁrst noted in 1956 (Stewart et al. 1956). Many
case–control studies have found a consistent
association to suggest that radiographic exami-
nation of the abdomen of a pregnant woman
produces a proportional increase in risk of
about 40% (Doll and Wakeford 1997). The
evidence for causality and for uncertainty is
well described (Boice and Miller 1999; Doll
and Wakeford 1997). The most notable reason
for doubt of a true association is the lack of evi-
dence in cohort studies for an increased risk of
leukemia in children exposed to radiation
in utero during the atomic bomb blasts in
Japan. Furthermore, several recent studies have
not found a significant association between
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childhood leukemia and X-ray examinations in
the mother during pregnancy (Meinert et al.
1999; Naumberg et al. 2001; Shu et al. 2002).
This apparent decrease in risk over time may
be attributable to declining exposures to ioniz-
ing radiation (decreased dose) and to the
increasing use of diagnostic ultrasound in place
of diagnostic X rays during pregnancy (Shu
et al. 2002). 
Postnatal exposure to ionizing radiation.
Postnatal exposure to ionizing radiation has
been demonstrated to increase the risk of
childhood leukemia, most notably from the
World War II atomic bomb blasts and radio-
therapy for benign disease. Children and ado-
lescents exposed to 1 gray after the bombings
were at elevated risk for leukemia (RR = 7.1)
and developed leukemia in less time when
compared with adults (Boice 1996). Several
studies have identified an increased risk for
childhood leukemia or death due to leukemia
secondary to radiotherapy of benign disease
(Darby et al. 1987; Davies et al. 1961; Murray
et al. 1959; Ron et al. 1988) whereas others
have not (Lundell and Holm 1996) (Table 1).
This risk appears to be associated with thera-
peutic radiation for thymus enlargement,
ankylosing spondylitis, and ringworm.
Although inconclusive, to date, radiation
exposure secondary to the Chernobyl accident
has not been shown to increase the risk of
leukemia in children who were exposed after
birth (Moysich et al. 2002; Parkin et al. 1993,
1996; Sali et al. 1996). Recent studies have
shown mixed results regarding exposure to
diagnostic X rays during the postnatal period
and the risk for childhood leukemia (Meinert
et al. 1999; Shu et al. 2002) (Table 1). Shu
et al. (2002) found no signiﬁcant risk for ALL,
even if there were exposure to three or more
rays (OR = 1.2; 95% CI, 1.0–1.6). They did
note a signiﬁcant risk for children with pre-B
cell ALL, most notably if three or more X rays
were performed (OR = 3.2; 95% CI, 1.5–7.2)
and if the child was older than 5 years
(OR = 3.8; 95% CI, 1.1–13.3). Meinert et al.
(1999) found that exposure to four or more
X rays in the postnatal period did not con-
tribute a signiﬁcant risk to childhood leukemia
(OR = 2.3; 95% CI, 0.8–6.5); however, the
risk was not evaluated by immunophenotype.
Overall, postnatal X-ray studies do not appear
to signiﬁcantly increase the risk of childhood
leukemia. Increased risk for speciﬁc immuno-
phenotypes may result from certain biases, but
this may be an area for further study. 
Nonionizing radiation. Numerous epi-
demiologic studies have been conducted to
determine whether an association exists
between exposure to nonionizing EMFs and
childhood leukemia; some have found a small
association (Ahlbom et al. 2000; Greenland
et al. 2000; Hatch et al. 1998; Rivard and
Deadman 2003; Savitz et al. 1990) while oth-
ers have not (Kleinerman et al. 2000; Linet
et al. 1997; Myers et al. 1990). The inconsis-
tent results of the EMF and childhood
leukemia studies may be due in part to differ-
ing methods for assessing residential magnetic
ﬁeld exposures and unmeasured EMF charac-
teristics (Bowman and Thomas 2001; Brain
et al. 2003; Hardell et al. 1995). Furthermore,
investigations of animals with exposure to
much higher levels of EMFs than humans have
not shown increased risk for hematopoietic
neoplasia (Brain et al. 2003). 
Ahlbom et al. (2000) conducted a pooled
analysis of data collected for nine studies. For
the 44 children with leukemia and 62 control
children with high estimated residential EMF
exposure, the estimated summary relative risk
was 2.00 (95% CI, 1.3–3.1). Adjusting for
potential confounding variables did not appre-
ciably change the results, but selection bias may
have accounted for some of the increase. Linet
et al. (1997) conducted a case–control study
with actual measurements of EMFs in the
homes of > 1,200 study subjects near the time
of the diagnosis of ALL. Overall, there was no
statistically significant increased risk of ALL
with increasing exposure to residential magnetic
ﬁelds (OR = 1.24; 95% CI, 0.86–1.79) for the
highest exposure category compared with the
lowest. Furthermore, no increased risk of ALL
was found based on EMF levels for homes in
which the mother resided during pregnancy
with the index child (Linet et al. 1997). For
additional information on nonionizing radia-
tion, see Supplemental Material (http://www.
ehponline.org/docs/2006/9023/abstract.html).
Chemicals. The chemical classes most com-
monly associated with childhood leukemia are
hydrocarbons and pesticides. Studies have
examined the relationship between childhood
leukemia and direct exposure to these chemi-
cals (e.g., use of pesticides in the home)
(Freedman et al. 2001; Lowengart 1987) as
well as secondary exposure, such as to parents’
clothing worn in an occupational setting where
hydrocarbons are used and brought into the
home to be laundered (Buckley et al. 1989;
Lowengart 1987; Shu et al. 1999b). 
Hydrocarbons. Hydrocarbons are organic
compounds made up primarily of carbon and
hydrogen atoms. Examples of hydrocarbon
compounds include gasoline and trichloroeth-
ylene (spot remover). Hydrocarbons are
found in many household and industrial
products including paint removers and thin-
ners, and solvents, which are used to dissolve
other chemical substances. 
The most widely recognized hydrocarbon is
benzene, a ubiquitous chemical used in the
manufacture of paints and plastics and as a con-
stituent in motor fuels and hobby glues. It is
also formed during incomplete combustion of
fossil fuels (i.e., petroleum products, coal).
Benzene is a known human carcinogen. It has a
strong positive exposure–response relationship
with leukemia, particularly AML, at a range of
exposures not much higher than the current
legal standard for workers as recommended by
the National Institute for Occupational Safety
and Health (Rinsky 1981). A recent occupa-
tional study (Glass 2003) found excess risk for
leukemia associated with cumulative benzene
exposures and benzene exposure intensities at
lower levels (< 60 ppm-years) than had been
Table 1. Postnatal ionizing radiation exposure from diagnostic X rays and radiotherapy and the risk of childhood leukemia.
RR or OR
Reference Study design Study question No. Results (95% CI)
Diagnostic X rays
Shu et al. 2002 Retrospective  Risk of ALL from exposure to diagnostic  3,828 No increased risk for any X rays done OR 1.1 (0.9–1.2)
case control X rays  No increased risk for ≥ 3 X rays OR 1.2 (1.0–1.6)
Increase risk for pre-B cell ALL OR 3.2, (1.5–7.2)
Meinert et al. Retrospective  Risk of leukemia in children from  437 No signiﬁcant increase in risk if exposed to  OR 2.3 (0.8–6.5)
1999 case control exposure to diagnostic X rays ≥ 4 X rays
Radiotherapy
Murray et al.  Retrospective  Risk of leukemia in children exposed to  2,750 Greater than expected numbers of leukemia  Ratio of observed to 
1959 case control ionizing radiation for thymic enlargement deaths if treated for thymic enlargement expected deaths = 4.5
Darby et al.  Prospective Risk of cancer in children who received  > 14,000 Increase in leukemia mortality in children treated 3-fold increased risk 
1987a radiotherapy for ankylosing spondylitis with radiotherapy for ankylosing spondylitis RR greatest for AML
Lundell and  Retrospective  Increased risk of mortality from leukemia  > 14,000 No excess risk of mortality from leukemia  RR = 3.2 from dose of 
Holm 1996 cohort after irradiation for skin hemangioma No signiﬁcant association between childhood  > 0.01–0.10 to > 0.10 
leukemia and radiation dose gray (95% CI, 1.0–7.4)
aThe observed death rate for children with leukemia increased over the ﬁrst 5 years of observation, then gradually decreased previously reported (as high as 220 ppm-years)
(Rushton and Romaniuk 1997; Schnatter et al.
1996). For additional information on benzene,
see Supplemental Material (http://www.
ehponline.org/docs/2006/9023/abstract.html).
Freedman et al. (2001) conducted a case-
control study of 640 subjects to examine the
relationship between parental hobbies and
home projects and incidence of childhood
leukemia. ALL had a statistically significant
association with prenatal exposure to painted
homes (> 4 rooms) (OR = 1.7; 95% CI,
1.1–2.7) and to artwork with solvents
(OR = 4.1; 95% CI, 1.1–15.1). However, the
study was limited by the lack of information
about the child’s proximity to the activity and
the timeframe of exposure.
In a review by Savitz and Chen (1990) of
seven published epidemiologic studies of the
association between parental occupation and
childhood leukemia, exposure to paints and
pigments yielded the most consistently positive
results, with several studies producing ORs for
ALL and AML of ≥ 1.5. Paternal occupations
most associated with increased risk for child-
hood leukemia in the review included painter,
motor vehicle–related worker and machinist or
factory worker. In one of the seven epidemio-
logic studies reviewed, paternal hydrocarbon
exposures (e.g., gas station attendant) appeared
to be related to both AML and ALL occurring
in children ≤ 1 year of age (Vianna et al.
1984), but this ﬁnding could not be conﬁrmed
by other studies that covered a broader age
range (Van Steensel-Moll et al. 1985). 
In a separate large case–control study, only
paternal long-term exposure to plastics during
the preconception period showed an increased
risk of childhood leukemia, though not statis-
tically significant (OR = 1.4; 95% CI,
1.0–1.9) (Shu et al. 1999b). 
There is much speculation about the
biological mechanism by which paternal
occupational exposures may affect the off-
spring’s risk for leukemia. Potential mecha-
nisms include genetic alteration of the father’s
sperm, which may transmit cancer suscepti-
bility to the child, transplacental fetal expo-
sure after the father brings a toxic exposure
into the home, and direct postnatal exposure
to chemicals brought home on the clothing
(e.g., off-gassing) (Buckley et al. 1989; Savitz
and Chen 1990) or indirect exposure through
breast-feeding. Exposure through breast milk,
however, is an unlikely mechanism as breast-
feeding has been associated with a reduced
risk of ALL (Shu et al. 1999a). The reduction
in risk was stronger with a longer duration of
breast-feeding.
Specific occupations found more fre-
quently among mothers of children with
leukemia include metal manufacturing or
processing, textiles, and pharmacist (Savitz
and Chen 1990; Van Steensel-Moll et al.
1985). Increased risk for ALL has been
described, in a case–control study of more
than 3500 children, with maternal occupa-
tional exposure to solvents (OR = 1.8; 95%
CI, 1.3–2.5) and paints (OR = 1.6; 95% CI,
1.2–2.2) during the preconception period
(OR = 1.6; 95% CI, 1.3–2.5), and during
pregnancy (OR = 1.7; 95% CI, 1.2–2.3), but
not during the postnatal period (Shu et al.
1999b). Despite these associations, no linear
dose–response relationship was observed in
this study for any maternal exposure during
any time period, and statistically significant
associations were found only when maternal
occupational exposures were short (equal or
below the median) (Shu et al. 1999b).
A recent study in California suggested that
children living in areas with high levels of point
source carcinogenic hazardous air pollutants
(HAPs) are at an increased risk of developing
leukemia (RR = 1.3; 95% CI, 1.13–1.6)
(Reynolds et al. 2003). Selected carcinogenic
HAPs included benzene, perchloroethylene,
and trichloroethylene. This study had several
limitations; most notably the extrapolation of
group exposure levels to individuals and exclu-
sion of indoor HAP sources (e.g., tobacco
smoke) as potential confounders of exposure
estimates (Reynolds et al. 2003). 
A recent, similar study in Great Britain
reported associations between birthplace of
children with leukemia and proximity to
industrial sites that release volatile organic
compounds, dioxins, 1,3-butadiene, and
benzo[a]pyrene (Knox 2005).
Pesticides. Many studies have suggested a
link between pesticide exposure and child-
hood leukemia. However, most of these stud-
ies are limited by the use of nonspecific
pesticide exposure information, small num-
bers of exposed children, and potential recall
bias. Some studies suggest that pesticide-
exposed fetuses and children are at higher
risks for cancer compared with adults. This
suggests that newborns and children may be
particularly sensitive to the carcinogenic
effects of pesticides (National Research
Council 1993; Zahm and Ward 1998). Most
children’s exposure to pesticides is from
home, lawn, and garden use (Grossman
1995). Other sources of exposure can include
local agricultural applications, contaminated
food, parental occupation, and pet products. 
In a large meta-analysis of epidemiologic
studies that investigated whether occupational
or residential exposure to pesticides by either
parents or children was related to increased
risk of childhood cancer, frequent occupa-
tional exposure or in-home pesticide use was
associated with childhood leukemia (Daniels
et al. 1997) (Table 2). Use of garden pesticides
or professional exterminations did not greatly
affect risk in this meta-analysis. Some studies
have reported increased risk with mothers who
had frequent prenatal pesticide exposure in the
garden (Infante-Rivard et al. 1999) or during
pregnancy (OR = 6.5; 95% CI, 1.5–59)
(Lowengart 1987) and increased risk during
childhood with garden insecticides (OR = 2.4;
95% CI, 1.3–4.3) and garden fungicides
(OR = 2.5; 95% CI, 1.0–6.2) (Menegaux
et al. 2006).
Children exposed to professional pest con-
trol services at any time 1 year before birth to
3 years after had increased risk as well
(OR = 2.8; 95% CI, 1.4–5.7) (Ma 2002)
(Table 2). In a review of 18 studies that
assessed the association between pesticide expo-
sure and childhood cancer, no clear patterns of
risk by which parent was exposed, by timing of
exposure, or by histologic type of leukemia
were apparent (Zahm and Ward 1998). 
In a recent case–control study conducted
in France, for the ﬁrst time insecticidal sham-
poo treatment of pediculosis was found to be
associated with childhood ALL and AML
(OR = 1.9; 95% CI, 1.2–3.3) (Menegaux
et al. 2006). Various insecticidal shampoos
were reported but only the association with
pyrethroid-based shampoo was statistically
significant (OR = 2.0; 95% CI, 1.1–3.4)
(Menegaux et al. 2006).
Alcohol, cigarette, and illicit drug use.
Studies have shown an increased risk for
AML, particularly among very young chil-
dren, associated with maternal alcohol con-
sumption during pregnancy (Shu et al. 1996;
Van Duijn et al. 1994). Shu et al. (1996)
examined the effect of alcohol consumption
on the risk of developing childhood leukemia,
beginning 1 month before and continuing
throughout the pregnancy. The risk for
AML with maternal alcohol consumption
(OR = 2.6; 95% CI, 1.4–5.1) was almost
twice that of ALL. Paternal alcohol consump-
tion before conception did not appear to
increase risk (Shu et al. 1996). 
It is unclear whether maternal or paternal
cigarette smoking before or during pregnancy
is a risk factor for developing childhood
leukemia (Brondum et al. 1999; Shu et al.
1996). Two studies found that the frequency,
amount, and duration of paternal smoking
before conception were related to signiﬁcantly
elevated risk, after adjusting for the effect of
maternal smoking (Ji et al. 1997; Sorahan
et al. 1995). Brondum et al. (1999), however,
found no association between the disease and
paternal smoking at any time. 
Maternal marijuana use before and during
pregnancy has been associated with childhood
AML and ALL. Despite a small sample size,
findings from a Children’s Cancer Group
study showed a 10-fold risk of childhood
AML associated with maternal use of mari-
juana just before or during pregnancy
(Robison et al. 1989). The authors concluded
that, because marijuana has been shown to be
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it may be leukomogenic, either alone or in
combination with a cofactor. 
Genetics
Childhood leukemia and other cancers may
stem from a combination of genetic suscepti-
bility factors and environmental exposures.
The importance of in utero genetic events has
been suspected for many years based on con-
cordance studies on twins with leukemia
(Clarkson and Boyse 1971; Greaves et al.
2003; Zipf et al. 2000). This is especially true
among identical twins. An identical twin is
twice as likely as the general population to
develop leukemia if his or her twin developed
the illness before the age of 7 years (Miller
1967; Zipf et al. 2000). Twins who reach age
15 years without developing leukemia do
not appear to be at higher risk of developing
the disease. 
This concept that some cases of childhood
leukemia originate in utero also is the result of
genetic studies that have found leukomogenic
translocations or clonotypic gene fusion
sequences that match that of later leukemic
blasts in heelstick blood samples (Guthrie
cards) from newborns who later developed
ALL (Gale et al. 1997; Greaves et al. 2003).
Infant acute leukemia commonly involves
gene fusions with the MLL gene. Because
(MLL+) acute leukemia can arise after
chemotherapy with DNAt2 inhibitors, it is
possible that these substances, which are
found naturally in certain foods and beverages
(e.g., fruits and vegetables, legumes, coffee),
may contribute toward infant leukemia
(Alexander et al. 2001; Ross et al. 1996;
Spector et al. 2005). 
Studies of archived neonatal blood spots in
which a specific gene fusion occurs [t(1;19)/
E2A-PBX1] support the theory that not all
cases of childhood ALL develop in utero
(Wiemels et al. 2002). The association of
leukemogenesis in children with metabolizing
gene variants suggests a causal relationship to
environmental exposures that may occur dur-
ing the postnatal period. Increased risk of
childhood leukemia has recently been associ-
ated with genetic polymorphisms that disrupt
the hosts’ abilities to properly metabolize and
transport xenobiotic exposures (Canalle et al.
2004; Infante-Rivard and Jacques 2000;
Krajinovic et al. 2002). Furthermore, poly-
morphic genes encoding carcinogen- and
drug-metabolizing enzymes may not only
increase the risk of ALL but also inﬂuence the
risk of relapse in patients and therefore help to
predict disease outcome. For example, the
prognosis of patients with cytochrome P450
1A1 (CYP1A1) and NAD(P)H quinine oxi-
doreductase 1 (NQO1) variants has been
found to be worse than that of patients who
lack these variants (Krajinovic et al. 2001). 
Although genetic syndromes account for
only a small proportion of childhood
leukemias, certain inherited diseases are asso-
ciated with a higher risk of developing
leukemia. Examples of these diseases include
Fanconi anemia (Swift 1971; Willis and
Lindahl 1987), Bloom syndrome (Miller
1968; Willis and Lindahl 1987), ataxia
telangiectasia (Toledano and Lange 1980),
Down syndrome (Dordelmann et al. 1998;
Robison et al. 1987), Shwachman syndrome
(Woods et al. 1981), and neurofibromatosis
(Shearer et al. 1994). These inherited diseases
are characterized by defective DNA repair,
chromosome aneuploidy (an abnormal num-
ber of chromosomes), or chromosomal abnor-
malities such as translocations. AML has a
higher incidence during the neonatal period
than ALL among children with Fanconi ane-
mia, Bloom syndrome, and Down syndrome. 
Siblings of children with leukemia are at
greater risk of developing leukemia than
children whose siblings do not have the dis-
ease (Draper et al. 1977; Heath and Moloney
1965). Also, a positive family history of
hematopoietic malignancies among first- or
second-degree relatives has been associated
with a small increased risk for childhood ALL.
Furthermore, the risk for ALL is not increased
in children with a family history of cancers
other than hematopoietic malignancies
(Infante-Rivard and Guiguet 2004). 
Infectious Agents and the
Population Mixing Theory
Several observations contribute to the theory
that a transmissible agent is potentially
involved in the oncogenic process of child-
hood leukemia. First, the peak incidence of
childhood leukemia and that of common
childhood infections both occur among chil-
dren 2–5 years of age, the age group least
likely to possess sophisticated immune systems
(Greaves 2002; Pierce 1936). Second, a viral
etiology has been shown for some animal and
human cancers (e.g., Epstein-Barr virus for
Burkitt lymphoma) (Greaves and Alexander
1993; Gross 1978). Third, evidence exists of an
apparent seasonal variation in the birth or onset
dates of childhood leukemia. Statistically signif-
icant seasonal variation for ALL with a peak in
the summer (Ross et al. 1999; Westerbeek et al.
1998), in the autumn–winter (Karimi et al.
Belson et al.
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Table 2. Pesticide exposure and the risk of childhood leukemia.
RR or OR 
Reference Study design Study question No. Results (95% CI)
Lowengart 1987 Retrospective Association between childhood leukemia  > 225 Increased risk for household use of pesticides by  OR 3.8 (1.4–13)
case control and occupational and home exposures either parent during pregnancy
Buckley et al.  Retrospective  Risk of AML as a result of parental  > 400 Increased risk for AML in all children for whom  OR 2.7 (1.0–7.0)
1989 case control occupational exposure to pesticides paternal pesticide exposure in jobs were 
held > 1,000 days
Increased risk for AML in children < 5 years of age  OR 11.4 (1.5–88.7)
for whom paternal pesticide exposure in jobs 
were held > 1,000 days
Leiss and Savitz  Retrospective Association between childhood cancer and  > 450 Association between childhood leukemia and use  OR 1.7–3.0 ( > 1) 
1995 case control home pesticide use of no-pest strips (contain dichlorvos) Highest for exposure 
during the last 3 
months of pregnancy
Meinert et al.  Retrospective  Association between childhood leukemia  > 400 Increased risk of leukemia in children whose  OR 2.5 (1.0–6.1)
1996 case control and pesticide exposure parents used pesticides in a garden from 2 years 
before birth to date of diagnosis
Daniels et al.  Meta-analysis  Association between childhood cancer and  31  For leukemia, ﬁve of nine occupational studies  Not applicable
1997 pesticide exposure studies showed a positive association
Ma et al. 2002b Prospective  Risk of childhood leukemia and household  > 300 Increased risk with use of professional pest  OR 2.8 (1.4–5.7)
case control pesticide use  control services
No signiﬁcant association for exposure to outdoor 
pesticides
Reynolds et al.  Retrospective  Risk of childhood cancer and agricultural  > 2,000 Childhood leukemia rates elevated in areas with  RR 1.48 (1.03–2.13)
2002 cohort pesticide use higher use of propargite, but no dose–response 
trend was noted2003) and in the early spring among 1- to
6-year-old children (Feltbower et al. 2001) have
been described. However, a large study of
> 15,000 cases of childhood leukemia born and
diagnosed in the United Kingdom found no
evidence of seasonality in either month of birth
or month of diagnosis in any subgroup of child-
hood cancer (Higgins et al. 2001). Last, an
excess of childhood leukemia has been found in
rural, potentially immunologically naïve, popu-
lations that have undergone an inﬂux of perma-
nent residents; this theory is known as
population mixing (Kinlen 1988, 1995).
Kinlen (1988) suggested that an extremely
infectious but not highly pathogenic agent
introduced into a previously unexposed com-
munity might cause an epidemic of ALL.
Susceptible individuals who live in rural areas in
which the population suddenly increases, or for
which the composition changes regularly, may
be exposed to infectious agents that are brought
into the area by new residents, possibly trigger-
ing a cluster of cases of ALL. The theory
implies that the differences in rates of leukemia
in rural areas are due to differences in herd, or
population, immunity. Results from other stud-
ies support this theory (Alexander et al. 1997;
Boutou et al. 2002; Gilman and Knox 1998;
Kinlen 1995; Kinlen et al. 1991; Koushik et al.
2001). For additional information on popula-
tion mixing, see Supplemental Material
(http://www.ehponline.org/docs/2006/9023/
abstract.html).
An alternative hypothesis to Kinlen’s sug-
gests that the mechanism of “delayed infection”
is responsible, and that an abnormal response to
the infection promotes a second event critical
for the development of ALL (Greaves and
Alexander 1993). Support of this hypothesis
comes from studies showing that children with
ALL are less likely to have had common infec-
tions, perhaps as a result of immunologic iso-
lation early in life (Ma 2002). Proposed
mechanisms for an abnormal response to an as
yet unidentified infectious agent might
include leukemogenicity of the virus itself,
which may directly infect and transform
B-precursor cells, or physical characteristics of
the virus that stimulate critical receptors for
cell growth (Greaves and Alexander 1993).
Other Important Variables
Maternal reproductive history and birth
characteristics. Conflicting results have been
reported from studies of the relationship
between maternal history of fetal loss and risk
for ALL or AML (Kaye et al. 1991; Ross et al.
1997; Yeazel 1995). A history of fetal loss
may reflect genetic predisposition, abnormal
intrauterine environment, or the effect of a
common environmental exposure (Ross et al.
1997).
The risk for childhood ALL has been
shown to be significantly higher among
children who were born when their parents
were older; signiﬁcant trends in ALL incidence
have been related to increasing mother’s
(> 35 years, p < 0.001) and father’s (> 40 years,
p < 0.002) ages (Dockerty et al. 2001). For chil-
dren born to mothers and fathers ≥ 40 years of
age, the odds ratio for offspring developing
childhood leukemia was 1.97 and 1.45, respec-
tively (Dockerty et al. 2001). 
Several studies have described an associa-
tion between increased birth weight and child-
hood ALL, particularly ALL developing early
in life (Kaye et al. 1991; Robison et al. 1987;
Ross et al. 1997). Increased birth weight has
been associated with a high rate of cell prolifer-
ation and with an increase in the number of
precursor cells that are at risk for malignant
transformation (Westergaard 1997). However,
birth weight tends to increase with maternal
age, which is also a known risk factor for ALL
in offspring (Dockerty et al. 2001). 
For information on medications/therapeu-
tic agents, military history and nutrition in rela-
tion to childhood leukemia, see Supplemental
Material (http://www.ehponline.org/docs/
2006/9023/abstract.html).
Conclusion
ALL and AML are the most common malig-
nancies of childhood. Despite many advances
in the treatment of childhood leukemia, the
causative factors of ALL and AML remain
unclear. Identifying risk factors for childhood
leukemia (e.g., environmental, genetic, infec-
tious) is an important step in the reduction of
the overall burden of the disease. In general,
benzene and ionizing radiation are two envi-
ronmental exposures strongly associated with
the development of childhood AML or ALL.
However, identifying other environmental
risk factors associated with leukemia is diffi-
cult for several reasons:
• inability to conﬁrm and quantify exposures; 
• lack of a prospective cohort; 
• presence of different variants of leukemia;
presence of confounders; and 
• inadequate understanding of the pathophys-
iology of leukemia (e.g., gene–environment
or infection–environment interaction). 
Future attempts to overcome these obsta-
cles (e.g., through improving laboratory
detection methods to confirm exposure;
prospective cohort studies; focusing on spe-
cific types of leukemia and specific chemical
agents) could possibly uncover other environ-
mental risk factors associated with childhood
leukemia and mitigate potentially harmful
exposures to reduce the risk for disease.
Future studies, when appropriate, should
attempt to use common questionnaires,
address timing and route of exposure, docu-
ment evidence that exposure has actually been
transferred from the workplace to the child,
and store biological samples when possible. 
REFERENCES
Ahlbom A, Day N, Feychting M, Roman E, Skinner, J, Dockerty J,
et al. 2000. A pooled analysis of magnetic ﬁelds and child-
hood leukaemia. Br J Cancer 83:692–698.
Alexander FE, Chan LC, Lam TH, Yuen P, Leung NK, Ha SY, et al.
1997. Clustering of childhood leukaemia in Hong Kong: asso-
ciation with the childhood peak and common acute lym-
phoblastic leukaemia and with population mixing. Br J
Cancer 75:457–463.
Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME,
Chan LC, et al. 2001. Transplacental chemical exposure
and risk of infant leukemia with MLL gene fusion. Cancer
Research 61:2542–2546.
Bhatia S. 2004. Inﬂuence of race and socioeconomic status on
outcome of children treated for childhood acute lym-
phoblastic leukemia. Curr Opin Pediatr 16:9–14.
Bleyer A, Sposto R, Sather H. 1998. In the United States, pedi-
atric brain tumors and other nervous system tumors are
now more common than childhood acute lymphoblastic
leukemia (ALL) and have a 3-fold greater national mortality
rate than ALL [Abstract]. Proc Am Soc Clin Oncol 17:389a. 
Boice J. 1996. Cancer following irradiation in childhood and
adolescence. Med Pediatr Onc (suppl)1:29–34.
Boice J, Miller R. 1999. Childhood and adult cancer after
intrauterine exposure to ionizing radiation. Teratology
59:227–233.
Boutou O, Guizard A-V, Slama R, Pottier D, Spira A. 2002.
Population mixing and leukaemia in young people around
the La Hague nuclear waste reprocessing plant. Br J Cancer
87:740–745.
Bowman JD, Thomas DC. 2001. Re: “Are children living near high-
voltage power lines at increased risk of acute lymphoblastic
leukemia?” Am J Epidemiol 153:615–617.
Brain JD, Kavet R, McCormick DL, Poole C, Silverman LB,.Smith
TJ, et al. 2003. Childhood leukemia: electric and magnetic
ﬁelds (EMF) as possible risk factors. Environ Health Perspect
111:962–970.
Brondum J, Shu XO, Steinbuch M, Severson RK, Potter JD,
Robison LL. 1999. Parental cigarette smoking and the risk of
acute leukemia in children. Cancer 85:1380–1388.
Buckley JD, Robison LL, Swotinsky R, Garabrant DH, LeBeau M,
Manchester P, et al. 1989. Occupational exposures of par-
ents of children with acute nonlymphoblastic leukemia: a
report from the Children’s Cancer Study Group. Cancer Res
49:4030–4037.
Canalle R, Burim RV, Tone LG, Takahashi CS. 2004. Genetic poly-
morphisms and susceptibility to childhood acute lympho-
blastic leukemia. Environ Mol Mutagen 43:100–109.
Clarkson B, Boyse EA. 1971. Possible explanation of high concor-
dance for acute leukemia in monozygous twins. Lancet
1:699–701.
Daniels JL, Olshan AF, Savitz DA. 1997. Pesticides and childhood
cancers. Environ Health Perspect 105:1068–1077.
Darby SC, Doll R, Gill SK, Smith PG. 1987. Long term mortality after
a single treatment course with X-rays in patients treated for
ankylosing spondylitis. Br J Cancer 55:179–190.
Davies A, Modan B, Djaldetti M, deVries A. 1961. Epidemiological
observations on leukemia in Israel. Arch Intern Med
108:86–90. 
Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ. 2001.
Case-control study of parental age, parity and socio-
economic level in relationship to childhood cancers. Int J
Epidemiol 30:1428–1437.
Doll R, Evans HJ, Darby SC. 1994. Paternal exposure not to blame.
Nature 367:678–680.
CORRECTION
In the Abstract and in the section “Risk
Factors,” the sentences “Only two environ-
mental risk factors (benzene and ionizing
radiation) have been signiﬁcantly linked to
ALL or AML” in the original manuscript
published online have been changed here
to “Only one environmental risk factor
(ionizing radiation) has been significantly
linked to ALL or AML.”
Acute leukemia in children
Environmental Health Perspectives • VOLUME 115 | NUMBER 1 | January 2007 143Doll R, Wakeford R. 1997. Risk of childhood cancer from fetal
irradiation. Br J Radiol 70:130–139.
Dordelmann M, Schrappe M, Reter A, Zimmerman M, Graf N,
Schott G, et al. 1998. Down’s syndrome in childhood acute
lymphoblastic leukemia: clinical characteristics and and
treatment outcome in four consecutive BFM trials, Berlin-
Frankfurt-Munster Group. Leukemia 12:645–651.
Draper GJ, Heaf MM, Kinnier Wilson LM. 1977. Occurrence of
childhood cancers among sibs and estimation of familial
risks. J Med Genet 14:81–90. 
Draper GJ, Stiller CA, Cartwright RA, Craft AW, Vincent TJ. 1993.
Cancer in Cumbria and in the vicinity of the Sellafield
nuclear installation, 1963–1990. BMJ 306:89–94.
Feltbower RG, Pearce MS, Dickinson HO, Parker L, McKinney PA.
2001. Seasonality of birth for cancer in Northern England,
UK. Paediatr Perinat Epidemiol 15:338–345.
Freedman MD, Stewart P, Kleinerman RA, Wacholder S, Hatch EE,
Tarone RE, et al. 2001. Household solvent exposures and
childhood acute lymphoblastic leukemia. Am J Public Health
91:564–567.
Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al.
1997. Backtracking leukemia to birth: identiﬁcation of clono-
typic gene fusion sequences in neonatal blood spots. Proc
Natl Acad Sci USA 94:13950–13954.
Gardner MJ. 1991. Father’s occupational exposure to radiation
and the raised level of childhood leukemia near the
Sellaﬁeld Nuclear Plant. Environ Health Perspect 94:5–7.
Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terrell JD.
1990. Results of case-control study of leukemia and lym-
phoma among young people near Sellaﬁeld nuclear plant in
West Cumbria. BMJ 300:423–429.
Gilman EA, Knox EG. 1998. Geographical distribution of birth
places of children with cancer in the UK. Br J Cancer 77:
842–849.
Glass DC. 2003. Leukemia risk associated with low-level benzene
exposure. Epidemiology 14:569–577.
Greaves MF. 2002. Childhood leukemia. BMJ 324:283–287.
Greaves MF, Alexander FE. 1993. An infectious etiology for com-
mon acute lymphoblastic leukemia in childhood? Leukemia
7(3):349–360.
Greaves MF, Maia AT, Wiemels JL, Ford AM. 2003. Leukemia in
twins: lessons in natural history. Blood 102:2321–2333.
Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. 2000.
A pooled analysis of magnetic ﬁelds, wire codes, and child-
hood leukemia, Childhood-EMF Study Group. Epidemiology
11:624–634.
Greenlee RT, Murray T, Bolden S, Wingo PA. 2000. Cancer statis-
tics 2000. CA Cancer J Clin 50:7–34.
Gross L. 1978. Viral etiology of cancer and leukemia: a look into
the past, present and future. Cancer Res 38:485–493.
Grossman J. 1995. What’s hiding under the sink: dangers of
household pesticides. Environ Health Perspect 103:550–554. 
Gurney JG, Severson RK, Davis S, Robison LL. 1995. Incidence of
cancer in children in the United States, sex, race, and 1-year
age-speciﬁc rates by histologic type. Cancer 75:2186–2195.
Hardell L, Holmberg B, Malker H, Paulsson LE. 1995. Exposure to
extremely low frequency electromagnetic ﬁelds and the risk
of malignant disease—an evaluation of epidemiological and
experimental ﬁndings. Eur J Cancer Prev 4(suppl 1):3–107.
Hatch EE, Linet MS, Kleinerman RA, Tarone RE, Severson RK,
Hartsock CT, et al. 1998. Association between childhood
acute lymphoblastic leukemia and use of electrical appli-
ances during pregnancy and childhood. Epidemiology
9:234–245.
Heath CW Jr, Moloney WC. 1965. Familial leukemia: ﬁve cases
of acute leukemia in three generations. N Engl J Med
272:882–887.
Higgins CD, dos-Santos-Silva I, Stiller CA, Swerdlow AJ. 2001.
Season of birth and diagnosis of children with leukaemia: an
analysis of over 15000 UK cases occurring from 1953-95. Br J
Cancer 84:406–412.
Hjalmars U, Kulldorff M, Gustafsson G. 1994. Risk of acute child-
hood leukemia in Sweden after the Chernobyl reactor acci-
dent. BMJ 309:154–157.
Infante-Rivard C, Guiguet M. 2004. Family history of hematopoi-
etic and other cancers in children with acute lymphoblastic
leukemia. Cancer Detect Prev 28:83–87.
Infante-Rivard C, Jacques L. 2000. Empirical study of parental
recall bias. Am J Epidemiol 152:480–486.
Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. 1999. Risk of
childhood leukemia associated with exposure to pesticides
and with gene polymorphisms. Epidemiology 10:481–487.
Ji BT, Shu XO, Linet M, Xheng W, Wacholder S, Gao YT, et al.
1997. Paternal cigarette smoking and risk for childhood
cancer among offspring of nonsmoking mothers. J Natl
Cancer Inst 89:238–244.
Kalwinsky DK, Rivera G, Dahl GV, Roberson P, George S, Murphy
SB, et al. 1985. Variation by race in presenting clinical and
biologic features of childhood acute lymphoblastic leukemia:
implications for treatment outcome. Leuk Res 9:817–823.
Karimi M, Yarmohammadi H. 2003. Seasonal variations in the
onset of childhood leukemia/lymphoma: April 1996 to March
2000, Shiraz, Iran. Hematol Oncol 21:51–55.
Kaye SA, Robison LL, Smithson WA, Gunderson P, King FL, Neglia
JP. 1991. Maternal reproductive history and birth character-
istics in childhood acute lymphoblastic leukemia. Cancer
68:1351–1355.
Kersey JH, Sabad A, Gajl-Peczalska K, Hallgren HM, Yunis EJ,
Nesbit ME. 1973. Acute lymphoblastic leukemia cells with T
(thymus-derived) lymphocyte markers. Science 183:
1355–1356.
Kinlen LJ. 1988. Evidence for an infective cause of childhood
leukaemia: comparison of a Scottish new town with nuclear
reprocessing sites in Britain. Lancet 322(8624):1323–1327.
Kinlen LJ. 1995. Epidemiologic evidence for an infective basis in
childhood leukaemia. Br J Cancer 71:1–5.
Kinlen LJ, Clarke K, Balkwill A. 1993. Paternal preconceptional
radiation exposure in the nuclear industry and leukaemia
and non-Hodgkin’s lymphoma in young people in Scotland.
BMJ 306:1153–1158.
Kinlen LJ, Hudson C, Stiller LA. 1991. Contacts between adults as
evidence for an infective origin of childhood leukemia: an
explanation for the excess near nuclear establishments in
West Berkshire? Br J Cancer 64:549–554.
Kleinerman RA, Kaune WT, Hatch EE, Wacholder S, Linet MS,
Robison LL, et al. 2000. Are children living near high-voltage
power lines at increased risk of acute lymphoblastic
leukemia? Am J Epidemiol 151:512–515.
Knox EG. 2005. Childhood cancers and atmospheric carcinogens.
J Epidemiol Community Health 59:101–105.
Koushik A, King WD, McLaughlin JR. 2001. An ecologic study of
childhood and population mixing in Ontario, Canada. Cancer
Causes Control 12:483–490.
Krajinovic M, Labuda D, Sinnett D. 2001. Childhood acute lym-
phoblastic leukemia: genetic determinants of susceptibility
and disease outcome. Rev Environ Health 16:263–279.
Krajinovic M, Labuda D, Sinnett D. 2002. Glutathione S-trans-
ferase P1 genetic polymorphisms and susceptibility to child-
hood acute lymphoblastic leukaemia. Pharmacogenetics
12:655–658.
Leiss JK, Savitz DA. 1995. Home pesticide use and childhood can-
cer: a case-control study. Am J Public Health 85:249–252.
Linet MS, Hatch EE, Kleinerman RA, Robison LL, Kaune WT,
Friedman DR, et al. 1997. Residential exposure to magnetic
ﬁelds and acute lymphoblastic leukemia in children. N Engl J
Med 337:1–7.
Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS. 1999. Cancer
surveillance series: recent trends in childhood cancer inci-
dence and mortality in the United States. J Natl Cancer Inst
91:1051–1058.
Little MP. 1990. A comparison between the risk of childhood
leukemia from parental exposure to radiation in the Sellaﬁeld
work force and those displayed among the Japanese atomic
bomb survivors. J Radiol Protection 10:185–198.
Lord BI. 1999. Transgenerational susceptibility to leukemia induc-
tion resulting from preconception, paternal irradiation. Int J
Radiat Biol 75:801–810.
Lowengart RA. 1987. Childhood leukemia and parent’s occupa-
tional and home exposures. J Natl Cancer Inst 79:39–46.
Lundell M, Holm LE. 1996. Mortality from leukemia after irradiation
in infancy for skin hemangioma. Radiat Res 145:595–601.
Ma X, Bufﬂer PA, Gunier RB, Dahl G, Smith MT, Reinier K, et al.
2002. Critical windows of exposure to household pesticides
and risk of childhood leukemia. Environ Health Perspect
110:955–960.
Mahoney MC, Moysich KB, McCarthy Jr PL, McDonald RC,
Stepanenko VF, Day RW, et al. 2004. The Chernobyl child-
hood leukemia study: background & lessons learned.
Environ Health 3(1):12; doi:10.1186/1476-069X-3-12 [Online 7
December 2005].
Margolin JF, Steuber CP, Poplack DG. 2001. Acute lymphocytic
leukemia. In: Principles and Practice of Pediatric Oncology
(Pizzo PA, Poplack DG, eds). Philadelphia:JB Lippincott,
489–544. 
McKinney PA, Alexander FE, Cartwright RA, Parker L. 1991.
Parental occupations of children with leukemia in west
Cumbria, north Humberside, and Gateshead. BMJ
302:681–687.
McLaughlin JR, King WD, Anderson TW, Clarke EA, Ashmore JP.
1993. Paternal radiation exposure and leukaemia in off-
spring: the Ontario case-control study. BMJ 307:959–966.
Meinert R, Kaletsch U, Kaatsch P, Schuz J, Michaelis J. 1999.
Associations between childhood cancer and ionizing radia-
tion: Results of a population-based case-control study in
Germany. Cancer Epidemiol Biomarkers Prev 8:793–799.
Menegaux F, Baruchel A, Bertrand Y, Lescoeur B, Leverger G,
Nelken B, et al. 2006. Household exposure to pesticides and
risk of childhood acute leukaemia. Occup Environ Med 63:
131–134.
Michaelis J, Kaletsch U, Burkart W, Grosche B. 1997. Infant
leukaemia after the Chernobyl accident [Letter]. Nature
387:246. 
Miller RW. 1967. Persons with exceptionally high risk of leukemia.
Cancer Res 27:2420–2423. 
Miller RW. 1968. Relationship between cancer and congenital
defects: an epidemiologic evaluation. J Natl Cancer Inst
40(5):1079–1085.
Moloney W. 1955. Leukemia in survivors of atomic bombing.
N Engl J Med 253:88–90. 
Moysich KB, Menezes RJ, Michalek AM. 2002. Chernobyl-related
ionising radiation exposure and cancer risk: an epidemiolog-
ical review. Lancet Oncol 3:269–279.
Murray R, Heckel P, Hempelmann L. 1959. Leukemia in children
exposed to ionizing radiation. N Engl J Med 261:585–589. 
Myers A, Cllyden A, Cartwright RA, Cartwright SC. 1990.
Childhood cancer and overhead powerlines: a case-control
study. Br J Cancer 62:1008–1014.
National Research Council. 1993. Pesticides in the Diet of Infants
and Children. Washington, DC:National Academy Press.
Naumberg E, Bellocco R, Cnattingius S, Hall P, Boice JD Jr, Ekbom
A. 2001. Intrauterine exposure to diagnostic x-rays and risk of
childhood leukemia subtypes. Radiat Res 156:718–723.
Neel JV, Schull WJ, eds. 1991. The Children of Atomic Bomb
Survivors. A Genetic Study. Washington, DC:National
Academy Press.
Noshchenko AG, Moysich KB, Bondar A. 2001. Patterns of acute
leukemia occurrence among children in the Chernobyl
region. Int J Epidemiol 30:125–129.
Parkin DM, Cardis E, Masuyer E, Friedl HP, Hansluwka H Bobev
D, et al. 1993. Childhood leukemia following the Chernobyl
accident: the European Childhood Leukemia-Lymphoma
Incidence Study (ECLIS). Eur J Cancer 29a:87–95.
Parkin DM, Clayton D, Black RJ, Masuyer E, Friedl HP, Ivanov E,
et al. 1996. Childhood leukaemia in Europe after Chernobyl:
5 year follow-up. Br J Cancer 73:1006-1012.
Petridou E, Trichopoulos D, Dessypris N, Flytzani V, Haidas S,
Kalmanti M, et al. 1996. Infant leukemia after in utero expo-
sure to radiation from Chernobyl. Nature 382:303–304.
Pierce M, 1936. Childhood leukemia. J Pediatr 8:66–95.
Pinkel D. 1993 Ethnicity and survival in children acute lymphoid
leukemia. Leukemia 7(suppl 2):S146–S147.
Pollock BH, DeBaun MR, Camitta BM, Shuster JJ, Ravindranath
Y, Pullen DJ, et al. 2000. Racial differences in the survival of
childhood B-precursor acute lymphoblastic leukemia: a
Pediatric Oncology Group study. J Clin Oncol 18:813–823.
Pui CH. 1997. Acute lymphocytic leukemia. Pediatr Clin North Am
44(4):831–846.
Pui CH. 2000. Acute lymphocytic leukemia in children. Curr Opin
Oncol 12:3–12.
Pui CH, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC,
et al. 2003. Results of therapy for acute lymphoblastic
leukemia in black and white children. JAMA 290:2001–2007.
Reynolds P, Behren JV, Gunier RB, Goldberg DE, Hertz A, Harnly
ME. 2002. Childhood cancer and agricultural pesticide use:
an ecologic study in California. Environ Health Perspect
110:319–324.
Reynolds P, Behren JV, Gunier RB, Goldberg DE, Hertz A, Smith
DF. 2003. Childhood cancer incidence rates and hazardous
air pollutants in California: an exploratory analysis. Environ
Health Perspect 111:663–668.
Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A,
et al., eds. 1998. SEER Cancer Statistics Review, 1973–1995.
NIH Publ no 98-2789. Bethesda, MD:National Cancer
Institute.
Rinsky RA. 1981. Leukemia in benzene workers. Am J Ind Med
2:217–245.
Rivard CE, Deadman JE. 2003. Maternal occupational exposure to
extremely low frequency magnetic ﬁelds during pregnancy
and childhood leukemia. Epidemiology 14:437–441.
Robison LL, Buckley JD, Daigle AE, Wells R, Benjamin D, Arthur
DC, et al. 1989. Maternal drug use and risk of childhood non-
lymphoblastic leukemia among offspring: an epidemiologic
Belson et al.
144 VOLUME 115 | NUMBER 1 | January 2007 • Environmental Health Perspectivesinvestigation implicating marijuana (a report from the
Children’s Cancer Study Group). Cancer 63:1904–1911.
Robison LL, Codd M, Gunderson P, Neglia JP, Smithson WA,
King FL. 1987. Birth weight as a risk factor for childhood
acute lymphoblastic leukemia. Pediatr Hematol Oncol
4:63–72.
Robison LL, Neglia JP, 1987. Epidemiology of Down syndrome and
childhood acute leukemia. Prog Clin Biol Res 246:19–32.
Roman E, Watson A, Beral V, Buckle S, Bull D, Baker K, et al.
1993. Case-control study of leukemia and non-Hodgkin’s
lymphoma among children aged 0-4 years living in west
Berkshire and north Hampshire health districts. BMJ
306:615–621.
Ron E. 1998. Ionizing radiation and cancer risk: evidence from epi-
demiology. Radiat Res 150:S30–S41.
Ron E, Modan B, Boice JD. 1988. Mortality after radiotherapy for
ringworm of the scalp. Am J Epidemiol 127:713–725.
Ross JA, Davies SM, Potter JD, Robison LL. 1994. Epidemiology of
childhood leukemia with a focus on infants. Epidemiol Rev
16:243–272.
Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL.
1996. Maternal exposure to potential inhibitors of DNA topo-
isomerase II and infant leukemia (United States): a report
from the Children’s Cancer Group. Cancer Causes Control
7:581–590.
Ross JA, Potter JD, Shu XO, Reaman GH, Lampkin B, Robison LL.
1997. Evaluating the relationship among maternal reproduc-
tive history, birth characteristics, and infant leukemia: a
report from the Children’s Cancer Group. Ann Epidemiol
7:172–179.
Ross JA, Severson RK, Swensen AR, Pollock BH, Gurney JG,
Robison LL. 1999. Seasonal variation in the diagnosis of
childhood cancer in the United States. Br J Cancer
81:549–553.
Rushton L, Romaniuk H. 1997. A case-control study to investigate
the risk of leukemia associated with exposure to benzene in
petroleum marketing and distribution workers in the United
Kingdom. Occup Environ Med 54:152–166.
Sali D, Cardis, E, Sztanyik L, Auvinen A, Bairakova A, Dontas N,
et al. 1996. Cancer consequences of the Chernobyl accident
in Europe outside the former USSR: a review. Int J Cancer
67:343–352.
Sandler DP, Ross JA. 1997. Epidemiology of acute leukemia in
children and adults. Semin Oncol 24:3–16.
Savitz DA, Chen J. 1990. Parental occupation and childhood can-
cer: review of epidemiologic studies. Environ Health
Perspect 88:325–337.
Schnatter RA, Armstrong TW, Nicolich MJ, Thompson FS, Katz
AM, Huebner, WW, et al. 1996. Lymphohaematopoietic
malignancies and quantitative estimates of exposure to ben-
zene in Canadian petroleum distribution workers. Occup
Environ Med 53:773–781.
Schulz KF, Grimes DA. 2002. Case-control studies: research in
reverse. Lancet 359:431–434.
Shearer P, Parham D, Kovnar E, Kun L, Rao B, Lobe T, et al. 1994.
Neuroﬁbromatosis type I and malignancy: review of 32 pedi-
atric cases treated at a single institution. Med Pediatr Oncol
22:78–83.
Shu XO, Linet MS, Steinbuch M, Wen WQ, Buckley JD, Neglia JP,
et al. 1999a. Breast feeding and risk of acute childhood
leukemia. J Natl Cancer Inst 91(20):1765–1772.
Shu XO, Potter JD, Linet MS, Severson RK, Han D, Kersey JH,
et al. 2002. Diagnostic x-rays and ultrasound exposure and
risk of acute lymphoblastic leukemia by immunophenotype.
Cancer Epidemiol Biomarkers Prev 11:177–185.
Shu XO, Reaman GH, Lampkin B, Sather, HN, Pendergrass TW,
Robison LL. 1994. Association of paternal diagnostic X-ray
exposure with risk of infant leukemia. Cancer Epidemiol
Biomarkers Prev 3:645–653.
Shu XO, Ross JA, Pendergrass TW, Reaman GH, Lampkin B,
Robison LL. 1996. Parental alcohol consumption, cigarette
smoking, and risk of infant leukemia: a Children’s Cancer
Group study. J Natl Cancer Inst 88(1):24–31.
Shu XO, Stewart P, Wen WQ, Han D, Potter JD, Buckley JD, et al.
1999b. Parental occupational exposure to hydrocarbons and
risk of acute lymphocytic leukemia in offspring. Cancer
Epidemiol Biomarkers Prev 8:783–791.
Sorahan T, Lancashire R, Prior P, Stewart A. 1995. Childhood can-
cer and parental use of alcohol and tobacco. Ann Epidemiol
5:354–359.
Spector LG, Xie Y, Robison LL, Heerema, NA, Hilden JM, Lange B,
et al. 2005. Maternal diet and infant leukemia: the DNA
topoisomerase II inhibitor hypothesis: a report from the chil-
dren’s oncology group. Cancer Epidemiol Biomarkers Prev
14:651–655.
Steiner M, Burkart W, Grosche B, Kaletsch U, Michaelis J. 1998.
Trends in infant leukemia in West Germany in relationship to
in utero exposure due to Chernobyl accident. Radiat Environ
Biophys 37:87–93.
Stewart A, Webb K, Giles D. 1956. Malignant disease in childhood
and diagnostic irradiation in utero [Letter]. Lancet 2:447.
Swensen AR, Ross JA, Severson RK, Pollock BH, Robison LL.
1997. The age peak in childhood acute lymphoblastic
leukemia: exploring the potential relationship with socioeco-
nomic status. Cancer 79(10):2045–2051.
Swift M. 1971. Fanconi’s anemia in the genetics of neoplasia.
Nature 230:370–373.
Toledano S, Lange B. 1980. Ataxia-telangiectasia and acute lym-
phoblastic leukemia. Cancer 45:1675–1678.
United Nations Scientific Committee on the Effects of Atomic
Radiation. 1994. Sources and Effects of Ionizing Radiation.
New York:United Nations.
Urquhart JD, Black RJ, Muirhead MJ, Sharp L, Maxwell M, Eden
OB, et al. 1991. Case-control study of leukaemia and
non-Hodgkin’s lymphoma in children in Caithness near the
Dounreay nuclear installation. BMJ 302:687–692.
Van Duijn CM, Van Steensel-Moll HA, Coebergh JW, Van Zanen
GE. 1994. Risk factors for childhood acute non-lymphocytic
leukemia: an association with maternal alcohol consumption
during pregnancy? Cancer Epidemiol Biomarkers Prevent
3:457–460
Van Steensel-Moll HA, Valkenbueg HA, Van Zanen GE. 1985.
Childhood leukemia and parental occupation, a register-
based case-control study. Am J Epidemiol 121:216–224.
Vianna NJ, Kovasznay B, Polan A, Ju C. 1984. Infant leukemia and
paternal exposure to motor vehicle exhaust fumes. J Occup
Med 26:679–682.
Watson GM. 1991. Leukaemia and paternal radiation exposure.
Med J Aust 154:483–487.
Westerbeek RM, Blair V, Eden OB, Kelsey AM, Stevens RF, Will
AM, et al. 1998. Seasonal variations in the onset of childhood
leukaemia and lymphoma. Br J Cancer 78:119–124. 
Westergaard T. 1997. Birth characteristics, sibling patterns, and
acute leukemia risk in childhood: a population-based cohort
study. J Natl Cancer Inst 89:939–947.
Wiemels JL, Leonard BC, Wang Y, Segal MR, Hunger SP, Smith
MT, et al. 2002. Site-speciﬁc translocation and evidence of
postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood
acute lymphoblastic leukemia. Proc Natl Acad Sci USA
99:15101–15106.
Willis A, Lindahl T. 1987. DNA ligase deﬁciency in Bloom’s syn-
drome. Nature 325:355–357. 
Woods WG, Roloff JS, Lukens JN, Krivit W. 1981. The occurrence
of leukemia in patients with the Shwachman syndrome.
J Pediatr 99:425–428.
Yeazel MW, Buckley JD, Woods WG, Ruccione K, Robison LL.
1995. History of maternal fetal loss and increased risk of
childhood acute leukemia at an early age, a report from the
Childrens Cancer Group. Cancer 75:17180–1727.
Yoshimoto Y, Kato H, Schull WJ. 1988. Risk of cancer among chil-
dren exposed in utero to A-bomb radiations, 1950-84. Lancet
2:665–669.
Yoshimoto Y, Neel JV, Schull WJ. 1990. Malignant tumors during
the ﬁrst 2 decades of life in the offspring of atomic bomb sur-
vivors. Am J Hum Genet 46:1041–1052.
Zahm SH, Devesa SS. 1995. Childhood cancer: overview of inci-
dence trends and environmental carcinogens. Environ
Health Perspect 103:177–184.
Zahm SH, Ward MH. 1998. Pesticides and childhood cancer.
Environ Health Perspect 106:893–908.
Zipf TF, Berg S, Roberts WM, Poplack DG, Steuber CP, Bleyer
WA. 2000. Childhood leukemias. In: Clinical Oncology
(Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds).
2nd ed. Philadelphia:Churchill Livingston, 2402–2429.
Acute leukemia in children
Environmental Health Perspectives • VOLUME 115 | NUMBER 1 | January 2007 145